U

Cognyxx Pharmaceuticals

Treatment for Cardiovascular and Neurodegenerative Disorders
Startup Pre-Funding Founded 2018 Health Tech & Life Sciences
Last Update Sep 4, 2025

Cognyxx Pharmaceuticals Business

Business models
B2B
Product stage
R&D
Employees
1-10

Sector

Health Tech & Life SciencesPharma & Medical Biotechnology

Target Customer

Healthcare & Life SciencesHealthcareProviders

Core Technology

Tags (3)

degenerative-diseasesneurosciencecardiology